The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells

EMBO Journal

Volumn 21, Issue 21, 2002, Pages 5766-5774

  Klejman, Agata ^a   Schreiner, Steven J ^a   Nieborowska Skorska, Malgorzata ^a   Slupianek, Artur ^a   Wilson, Matthew ^a   Smithgall, Thomas E ^a   Skorski, Tomasz ^a  

^a Temple University   (United States)

Author keywords

ABL; Activation; BCR; Hck; Pathway; STAT5

Indexed keywords

BCR ABL PROTEIN; HEMATOPOIETIC CELL KINASE; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; LEUKEMIA CELL; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

ANIMALS; CATALYSIS; DNA-BINDING PROTEINS; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID; MICE; MILK PROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036847027     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf562     Document Type: Article

References (64)

1. Briggs, S.D., Sharkey, M., Stevenson, M. and Smithgall, T.E. (1997) SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem., 272, 17899-17902.
2. Bunting, K.D., Bradley, H.L., Hawley, T.S., Moriggl, R., Sorrentino, B.P. and Ihle, J.N. (2002) Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood, 99, 479-487.
3. Carlesso, N., Frank, D.A. and Griffin, J.D. (1996) Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med., 183, 811-820.
4. Chai, S.K., Nichols, G.L. and Rothman, P. (1997) Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol., 159, 4720-4728.
5. Chaturvedi, P., Reddy, M.V. and Reddy, E.P. (1998) Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene, 16, 1749-1758.
6. Chin, H., Arai, A., Wakao, H., Kamiyama, R., Miyasaka, N. and Miura, O. (1998) Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood, 91, 3734-3745.
7. Clark, S.S. et al. (1988) Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science, 239, 775-777.
8. Corey, S.J. and Anderson, S.M. (1999) Src-related protein tyrosine kinases in hematopoiesis. Blood, 93, 1-14.
9. Corey, S., Eguinoa, A., Puyana-Theall, K., Bolen, J.B., Cantley, L., Mollinedo, F., Jackson, T.R., Hawkins, P.T. and Stephens, L.R. (1993) Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J., 12, 2681-2690.
10. Daley, G.Q., Van Etten, R.A. and Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
11. Danhauser-Riedl, S., Warmuth, M., Druker, B.J., Emmerich, B. and Hallek, M. (1996) Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Cancer Res., 56, 3589-3596.
12. deGroot, R.P., Raaijmakers, J.A., Lammers, J.W., Jove, R. and Koenderman, L. (1999) STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells. Blood, 94, 1108-1112.
13. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. and Lydon, N.B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med., 2, 561-566.
14. Gishizky, M.L. and Witte, O.N. (1992) Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science, 256, 836-839.
15. Gouilleux, F., Wakao, H., Mundt, M. and Groner, B. (1994) Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J., 13, 4361-4369.
16. Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P.K. and Groffen, J. (1990) Acute leukaemia in bcr/abl transgenic mice. Nature, 344, 251-253.
17. Horita, M., Andreu, E.J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prosper, F. and Fernandez-Luna, J.L. (2000) Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J. Exp. Med., 191, 977-984.
18. Horvath, C.M. and Darnell, J.E. (1997) The state of the STATs: Recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol., 9, 233-239.
19. Ilaria, R.L., Jr and Van Etten, R.A. (1996) P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem., 271, 31704-31710.
20. Ilaria, R.L., Hawley, R.G. and Van Etten, R.A. (1999) Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood, 93, 4154-4166.
21. Kazansky, A.V., Kabotyanski, E.B., Wyszomierski, S.L., Mancini, M.A. and Rosen, J.M. (1999) Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J. Biol. Chem., 274, 22484-22492.
22. Kieslinger, M., Woldman, I., Moriggl, R., Hofmann, J., Marine, J.C., Ihle, J.N., Beug, H. and Decker, T. (2000) Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev., 14, 232-244.
23. Klejman, A., Rushen, L., Morrione, A., Slupianek, A. and Skorski, T. (2002) Phosphatidylinositol-3 kinase inhibitors enhance the antileukemia effect of STI571. Oncogene, 21, 5868-5876.
24. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C. and Pawson, T. (1991) SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science, 252, 668-674.
25. Lerner, E.C. and Smithgall, T.E. (2002) SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nat. Struct. Biol., 9, 365-369.
26. Lionberger, J.M., Wilson, M.B. and Smithgall, T.E. (2000) Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. J. Biol. Chem., 275, 18581-18585.
27. Lowell, C.A., Soriano, P. and Varmus, H.E. (1994) Functional overlap in the src gene family: Inactivation of hck and fgr impairs natural immunity. Genes Dev., 8, 387-398.
28. Lowell, C.A., Niwa, M., Soriano, P. and Varmus, H.E. (1996) Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. Blood, 87, 1780-1792.
29. Maru, Y. (2001) Molecular biology of chronic myeloid leukemia. Int. J. Hematol., 73, 308-322.
30. Mui, A.L., Wakao, H., Kinoshita, T., Kitamura, T. and Miyajima, A. (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. EMBO J., 15, 2425-2433.
31. Nam, H.J., Haser, W.G., Roberts, T.M. and Frederick, C.A. (1996) Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism. Structure, 4, 1105-1114.
32. Nelson, K.L., Rogers, J.A., Bowman, T.L., Jove, R. and Smithgall, T.E. (1998) Activation of STAT3 by the c-Fes protein-tyrosine kinase. J. Biol. Chem., 273, 7072-7077.
33. Nieborowska-Skorska, M., Wasik, M.A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B. and Skorski, T. (1999) Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ ABL and is required for leukemogenesis. J. Exp. Med., 189, 1229-1242.
34. Nieborowska-Skorska, M., Hoser, G., Kossev, P., Wasik, M.A. and Skorski, T. (2002) Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood, 99, 4531-4539.
35. Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A.L. and Kitamura, T. (1999) STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J., 18, 4754-4765.
36. Okuda, K., Foster, R. and Griffin, J.D. (1999) Signaling domains of the βc chain of the GM-CSF/IL-3/IL-5 receptor. Ann. NY Acad. Sci., 872, 305-313.
37. Okutani, Y., Kitanaka, A., Tanaka, T., Kamano, H., Ohnishi, H., Kubota, Y., Ishida, T. and Takahara, J. (2001) Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene, 20, 6643-6650.
38. Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M. and Hynes, N.E. (1999) ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem., 274, 17209-17218.
39. Paukku, K., Valgeirsdottir, S., Saharinen, P., Bergman, M., Heldin, C.H. and Silvennoinen, O. (2000) Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGFβ-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem. J., 345, 759-766.
40. Pawson, T. and Gish, G.D. (1992) SH2 and SH3 domains: From structure to function. Cell, 71, 359-362.
41. Pendergast, A.M., Muller, A.J., Havlik, M.H., Maru, Y. and Witte, O.N. (1991) BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a nonphosphotyrosine-dependent manner. Cell, 66, 161-171.
42. Peng, Z.Y. and Cartwright, C.A. (1995) Regulation of the Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association. Oncogene, 11, 1955-1962.
43. Raitano, A.B., Whang, Y.E. and Sawyers, C.L. (1997) Signal transduction by wild-type and leukemogenic Abl proteins. Biochim. Biophys. Acta, 1333, F201-F216.
44. Reddy, E.P., Korapati, A., Chaturvedi, P. and Rane, S. (2000) IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene, 19, 2532-2547.
45. Saharinen, P., Ekman, N., Sarvas, K., Parker, P., Alitalo, K. and Silvennoinen, O. (1997) The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cδ. Blood, 90, 4341-4353.
46. Sattler, M. and Griffin, J.D. (2001) Mechanisms of transformation by the BCR/ABL oncogene. Int. J. Hematol., 73, 278-291.
47. Schindler, C. and Darnell, J.E., Jr (1995) Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu. Rev. Biochem., 64, 621-651.
48. Shtivelman, E., Lifshitz, B., Gale, R.P., Roe, B.A. and Canaani, E. (1986) Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell, 47, 277-284.
49. Shuai, K., Halpern, J., ten Hoeve, J., Rao, X. and Sawyers, C.L. (1996) Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene, 13, 247-254.
50. Sillaber, C., Gesbert, F., Frank, D.A., Sattler, M. and Griffin, J.D. (2000) STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood, 95, 2118-2125.
51. Skorski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M.Z., Wen, S.C., Zon, G., Gewirtz, A.M., Perussia, B. and Calabretta, B. (1995) Phosphatidylinositol-3 kinase activity is regulated by BCR/ ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood, 86, 726-736.
52. Skorski, T. et al. (1997) Transformation of hematopoietic cells by BCR/ ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J., 16, 6151-6161.
53. Skorski, T. et al. (1998) The SH3 domain contributes to BCR/ABL- dependent leukemogenesis in vivo: Role in adhesion, invasion and homing. Blood, 91, 406-418.
54. Slupianek, A., Schmutte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M.O., Pierce, A.J., Fishel, R. and Skorski, T. (2001) BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol. Cell, 8, 795-806.
55. Sonoyama, J. et al. (2002) Functional cooperation among Ras, STAT5 and PI3-K is required for full oncogenic activities of BCR/ABL in K562 cells. J. Biol. Chem., 277, 8076-8082.
56. Stein, P.L., Vogel, H. and Soriano, P. (1994) Combined deficiencies of Src, Fyn and Yes tyrosine kinases in mutant mice. Genes Dev., 8, 1999-2007.
57. Tauchi, T., Feng, G.S., Shen, R., Song, H.Y., Donner, D., Pawson, T. and Broxmeyer, H.E. (1994) SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase. J. Biol. Chem., 269, 15381-15387.
58. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D. and Kuriyan, J. (1993) Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell, 72, 779-790.
59. Warmuth, M., Bergmann, M., Priess, A., Hauslmann, K., Emmerich, B. and Hallek, M. (1997) The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J. Biol. Chem., 272, 33260-33270.
60. Weng, Z., Rickles, R.J., Feng, S., Richard, S., Shaw, A.S., Schreiber, S.L. and Brugge, J.S. (1995) Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol. Cell. Biol., 15, 5627-5634.
61. Wilson, M.B., Schreiner, S.J., Choi, H.-J., Kamens, J. and Smithgall, T.E. (2002) Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Oncogene, in press.
62. Xie, S., Wang, Y., Liu, J., Sun, T., Wilson, M.B., Smithgall, T.E. and Arlinghaus, R.B. (2001) Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene, 20, 6188-6195.
63. Yamashita, H., Xu, J., Erwin, R.A., Farrar, W.L., Kirken, R.A. and Rui, H. (1998) Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. J. Biol. Chem., 273, 30218-30224.
64. Zou, X. and Calame, K. (1999) Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J. Biol. Chem., 274, 18141-18144.